NCT00239447View on ClinicalTrials.gov

Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD

PHASE3CompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

November 26, 2002

Primary Completion Date

April 29, 2004

Study Completion Date

April 29, 2004

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Tiotropium

DEVICE

HandiHaler

DEVICE

Respimat SMI

Trial Locations (11)

27157

Wake Forest University School of Medicine, Winston-Salem

29303

Spartanburg Medical Research, Spartanburg

55407

Minisota Lung Center, Minneapolis

71103

LSU MC-Sheveport, Shreveport

72205

Division of Pulmonary and Critical Care Medicine, Little Rock

92120

Boehringer Ingelheim Investigational Site, San Diego

95128

San Jose Clinical Research, San Jose

95207

Boehringer Ingelheim Investigational Site, Stockton

98405

Boehringer Ingelheim Investigational Site, Tacoma

80206-2762

National Jewish Medical and Research Center, Denver

H2X 2P4

Montreal Chest Institute - McGill University Health Centre, Montreal

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY